Arcellx

ACLX

ACLX Arcellx NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    ACLX Chart
    See on advanced chart >

    About

    Arcellx, Inc. was incorporated in Delaware in December 2014. They are a clinical-stage biotechnology company reimagining cell therapy by developing innovative immunotherapies for patients with cancer and other incurable diseases. Their novel synthetic binding...
    • Highlight
      A company that develops innovative immunotherapies for cancer
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      02/04/2022
    • Established Date
      Invalid Date
    • Full-time Employees
      130
    • Address
      800 Bridge Parkway Redwood City CA 94065
    • Tel
      1-240-3270603
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock